Clinic Discussed Stem Cell Joint Therapy Options
Springs Rejuvenation outlined an approach to joint wellness using stem cells and exosomes.
Updated on Oct. 12, 2026 in Arthritis
Live Poll
Would you consider undergoing an experimental medical procedure that has not yet received FDA approval?
Springs Rejuvenation recently published an educational article detailing its use of stem cell and exosome joint therapy protocols. This clinic, which operates in five U.S. cities, frames the therapy as a potential minimally invasive alternative to surgical joint intervention.
Why it matters
Patients seeking alternatives to traditional joint surgery often look to biologic therapies to manage musculoskeletal health. Understanding the difference between therapies performed in supervised clinical settings and those granted full FDA approval is a key step in evaluating joint treatment options.
A 2021 study published in the Journal of Translational Medicine evaluated the use of exosome-based biologics for musculoskeletal applications. This research serves as a scientific basis for exploring non-surgical therapies, though the therapy itself is not an FDA-approved medical treatment.
The players
Springs Rejuvenation
A clinic group that offers physician-supervised joint wellness protocols at five locations.
The details
The clinic employs a Stem 3 Protocol to administer stem cells and exosomes to target joint tissues. This procedure utilizes a micro FUE instrument measuring 0.9mm to perform the treatment. While the formula is produced in an FDA-approved lab, the clinical application remains outside the scope of currently FDA-approved therapies.
Timeline
A 2021 study examined the use of exosome-based biologics.
Springs Rejuvenation published its article on October 11, 2026.
Health Landscape
This approach sits within the evolving field of regenerative medicine that relies on research like the 2021 Journal of Translational Medicine study. It reflects a broader trend of clinics investigating minimally invasive alternatives to standard surgical joint procedures.
If you are considering non-surgical options for joint pain, it is vital to discuss the difference between research-based therapies and FDA-approved treatments with your physician. Ask your doctor about the risks, benefits, and evidence supporting any clinic-offered biologics for your specific condition.
The takeaway
While interest in biologic joint therapy grows, patients should distinguish between laboratory-grade products and FDA-approved clinical treatments. Always consult with an orthopedic specialist to determine if a minimally invasive approach is appropriate for your joint health needs.
Further reading
For more information on managing chronic joint pain and exploring new treatment developments, visit our Arthritis section.
Source note: This article includes information reported by Trinidad Express Newspapers.
Live Poll
Would you consider undergoing an experimental medical procedure that has not yet received FDA approval?
